Medscape

Key Risk Factors Identified for Left Ventricular Systolic Dysfunction in Systemic Sclerosis

Demographic, systemic sclerosis (SSc)-specific, and cardiac factors raised the risk for left ventricular systolic dysfunction (LVSD) in a study of patients with SSc. Researchers used the Johns Hopkins ...
MedPage Today

Diastolic Dysfunction May Predict Rapid Cardiomyopathy Progression in Duchenne Muscular Dystrophy

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...
Medscape

OPTIMIZE-HF highlights differences between HF with reduced vs preserved systolic function

To distinguish the two groups, you really need to see the echocardiogram and the measurement of LVEF. "That doesn't preclude that these medications could have a longer-term benefit—maybe the ...
Medical Dialogues

Beta-Blockers Discontinuation Safe After One Year in Selected Patients after MI: SMART-DECISION Trial

The SMART-DECISION trial has found that in stabilized patients after myocardial infarction (MI) without heart failure or left ventricular systolic dysfunction, discontinuing beta-blockers after one ...
BioWorld

EDG-7500 improves diastolic performance in animal models of pacing induced LV systolic dysfunction

Researchers from Edgewise Therapeutics Inc. presented preclinical data for the cardiac sarcomere modulator, EDG-7500, which is being developed for the treatment of hypertrophic cardiomyopathy (HCM) ...
HealthDay on MSN

ACC: Discontinuing β-blockers noninferior for stabilized acute MI

For stabilized acute myocardial infarction (AMI) without left ventricular systolic dysfunction or heart failure, discontinuing β-blockers after one year or longer is noninferior to continuing ...